BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18720856)

  • 1. [Microscopical study of original plant of Chinese drug "Dragon's Blood" Dracaena cochinchinensis and distribution and constituents detection of its resin].
    Fan LL; Tu PF; He JX; Chen HB; Cai SQ
    Zhongguo Zhong Yao Za Zhi; 2008 May; 33(10):1112-7. PubMed ID: 18720856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new dihydrochalcone from dragon's blood, red resin of Dracaena cochinchinensis.
    Yong KL; Lv JC; Zhang TB; Xu LR; Chen X
    Nat Prod Res; 2008 Dec; 22(18):1624-6. PubMed ID: 19085419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screen of micro-organisms for inducing the production of dragon's blood by leaf of Dracaena cochinchinensis.
    Wang XH; Zhang CH; Wang Y; Gomes-Laranjo J
    Lett Appl Microbiol; 2010 Nov; 51(5):504-10. PubMed ID: 20860774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dracaenogenins A and B, new spirostanols from the red resin of Dracaena cochinchinensis.
    Zheng QA; Li HZ; Zhang YJ; Yang CR
    Steroids; 2006 Feb; 71(2):160-4. PubMed ID: 16271273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoids produced by tissue culture of Dracaena cambodiana.
    Wang H; Luo G; Wang J; Shen H; Luo Y; Dai H; Mei W
    Nat Prod Commun; 2014 Jan; 9(1):39-40. PubMed ID: 24660458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raman spectroscopic analysis of dragon's blood resins-basis for distinguishing between Dracaena(Convallariaceae), Daemonorops(Palmae) and Croton(Euphorbiaceae).
    Edwards HG; de Oliveira LF; Prendergast HD
    Analyst; 2004 Feb; 129(2):134-8. PubMed ID: 14752556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chalcane-stilbene conjugates and oligomeric flavonoids from Chinese Dragon's Blood produced from Dracaena cochinchinensis.
    Hao Q; Saito Y; Matsuo Y; Li HZ; Tanaka T
    Phytochemistry; 2015 Nov; 119():76-82. PubMed ID: 26452504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of dragon's blood in Dracaena cochinchinensis plants by inoculation of Fusarium proliferatum.
    Wang XH; Zhang C; Yang LL; Gomes-Laranjo J
    Plant Sci; 2011 Feb; 180(2):292-9. PubMed ID: 21421373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoid dimers from the total phenolic extract of Chinese dragon's blood, the red resin of Dracaena cochinchinensis.
    Pang DR; Su XQ; Zhu ZX; Sun J; Li YT; Song YL; Zhao YF; Tu PF; Zheng J; Li J
    Fitoterapia; 2016 Dec; 115():135-141. PubMed ID: 27769819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydrochalcones and homoisoflavanes from the red resin of Dracaena cochinchinensis (Chinese dragon's blood).
    Su XQ; Song YL; Zhang J; Huo HX; Huang Z; Zheng J; Zhang Q; Zhao YF; Xiao W; Li J; Tu PF
    Fitoterapia; 2014 Dec; 99():64-71. PubMed ID: 25218969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome profiling reveals candidate flavonoid-related genes during formation of dragon's blood from Dracaena cochinchinensis (Lour.) S.C.Chen under conditions of wounding stress.
    Sun HF; Song MF; Zhang Y; Zhang ZL
    J Ethnopharmacol; 2021 Jun; 273():113987. PubMed ID: 33667570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Formation of blood resin in abiotic Dracaena cochinchinensis inoculated with Fusarium 9568D].
    Jiang DF; Ma P; Yang J; Wang X; Xu K; Huang Y; Chen S
    Ying Yong Sheng Tai Xue Bao; 2003 Mar; 14(3):477-8. PubMed ID: 12836567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural potential therapeutic agents of neurodegenerative diseases from the traditional herbal medicine Chinese dragon's blood.
    Li N; Ma Z; Li M; Xing Y; Hou Y
    J Ethnopharmacol; 2014 Mar; 152(3):508-21. PubMed ID: 24509154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimeric chalchonoids from the total phenolic extract of Chinese dragon's blood (the red resin of Dracaena cochinchinensis).
    Pang DR; Zou QY; Zhu ZX; Wang XY; Pei YJ; Huo HX; Zhao YF; Tu PF; Zheng J; Li J
    Fitoterapia; 2021 Oct; 154():105029. PubMed ID: 34506872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavylium chromophores as species markers for dragon's blood resins from Dracaena and Daemonorops trees.
    Sousa MM; Melo MJ; Parola AJ; Seixas de Melo JS; Catarino F; Pina F; Cook FE; Simmonds MS; Lopes JA
    J Chromatogr A; 2008 Oct; 1209(1-2):153-61. PubMed ID: 18817913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homoisoflavonoid derivatives from the red resin of Dracaena cochinchinensis.
    Pang DR; Pan B; Sun J; Sun H; Yao HN; Song YL; Zhao YF; Tu PF; Huang WZ; Zheng J; Li J
    Fitoterapia; 2018 Nov; 131():105-111. PubMed ID: 30339923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cochinchinenin--a new chalcone dimer from the Chinese dragon blood].
    Zhou ZH; Wang JL; Yang CR
    Yao Xue Xue Bao; 2001 Mar; 36(3):200-4. PubMed ID: 12580088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous quantification of five major constituents in stems of Dracaena plants and related medicinal preparations from China and Vietnam by HPLC-DAD.
    Fan LL; Tu PF; Chen HB; Cai SQ
    Biomed Chromatogr; 2009 Nov; 23(11):1191-200. PubMed ID: 19488967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the chemical profiles and anti-platelet aggregation effects of two "Dragon's Blood" drugs used in traditional Chinese medicine.
    Yi T; Chen HB; Zhao ZZ; Yu ZL; Jiang ZH
    J Ethnopharmacol; 2011 Jan; 133(2):796-802. PubMed ID: 21073937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study on volatile metabolites profile of Dracaena cochinchinensis (Lour.) S.C. Chen xylem with and without resin using GC-MS.
    Teng Z; Zhang M; Meng S; Dai R; Meng W; Deng Y; Huang L
    Biomed Chromatogr; 2015 Nov; 29(11):1744-9. PubMed ID: 25973719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.